Thousands ordered to evacuate as dam nears failure on Oahu
01:50
Urgent manhunt underway to find suspect who killed Chicago college student
01:29
Lines at TSA checkpoints grow longer amid spring break travel rush
01:57
U.S. speeding up Marine deployment to Mideast
01:48
Emotional moment high school senior wins hockey state championship after unthinkable tragedy
01:31
Some DHS contractors say they were asked to pay Trump ally Corey Lewandowski
01:16
Trump says he’s not sending ground troops to Iran
02:05
Missing American student found dead in Spain
01:31
Long airport security lines worsening, as TSA officers continue working without pay
01:57
Oil prices surge after attacks on energy sites
02:53
Second graders offer heartwarming marriage advice to their teacher
01:27
One dead after gondola crash at Swiss ski resort
01:16
U.S. college student goes missing in Spain
01:27
Potentially record-setting heat wave scorches western United States
01:46
Women allege labor rights icon Cesar Chavez sexually assaulted them
02:09
Nightly News
FDA advisory panel endorses breakthrough nasal spray treatment for depression
Catch up with NBC News Clone on today's hot topic: Fda Advisory Panel Endorses Breakthrough Nasal Spray Treatment For Depression 1442231363872 - Breaking News | NBC News Clone. Our editorial team reformatted this story for clarity and speed.
01:17
Copied
Esketamine is an antidepressant related to the anesthetic Ketamine, and is intended for people for whom nothing else had worked. Research shows that it can take only a matter of hours or days to work, unlike Prozac and other antidepressants that can take several weeks.Feb. 13, 2019
